This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ICON Announces Publication Of EGM Circular In Respect Of Proposed Conversion To Direct Listing Of Its Shares On NASDAQ

ICON plc , (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the publication and filing of a circular to shareholders convening an extraordinary general meeting to be held at 3.00 p.m. on December 17, 2012 at ICON plc Headquarters, South County Business Park, Leopardstown, Dublin 18, Ireland at which resolutions in connection with the proposed replacement of ICON’s NASDAQ listing for ADSs with a direct NASDAQ listing for ICON Shares will be considered and voted on.

The expected timetable in respect of the proposals is as follows:
Latest time and date for receipt of Forms of Proxy for Ordinary Shareholders for Extraordinary General Meeting    

13 December 2012

(6 p.m. GMT)
Extraordinary General Meeting 17 December 2012 (3 p.m. GMT)
Expected last day of dealings in Shares on Irish Stock Exchange 29 January 2013

Expected date of Irish Stock Exchange Delisting with effect from 6.30 a.m. (GMT)
30 January 2013
Expected date of commencement of direct trading of Shares on NASDAQ 4 February 2013

A copy of the Circular is available in the investor relations section of ICON’s website at

A copy of the Circular is also being submitted to the Irish Stock Exchange, and will shortly be available for inspection at:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.81 -0.87%
GOOG $699.13 0.49%
FB $118.00 -0.05%
TSLA $213.46 -4.10%
YHOO $37.00 2.80%


Chart of I:DJI
DOW 17,659.93 +8.67 0.05%
S&P 500 2,055.29 +4.17 0.20%
NASDAQ 4,734.0610 +8.4220 0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs